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Objectives: Although Staphylococcus aureus and Group B streptococcus (GBS) are major causes of
neonatal sepsis in sub-Saharan Africa, it is unclear how these bacteria are transmitted to the neonate.
Methods: In a cohort of 377 Gambian women and their newborns, nasopharyngeal swabs were collected
at delivery (day 0), and 3, 6, 14 and 28 days later. Breast milk samples and vaginal swabs were collected
from the mother. Staphylococcus aureus and GBS were isolated using conventional microbiological
methods.
Results: Most womenwere carriers of S. aureus (264 out of 361 with all samples collected, 73.1%) at some
point during follow up and many were carriers of GBS (114 out of 361, 31.6%). Carriage of S. aureus was
common in all three maternal sites and GBS was common in the vaginal tract and breast milk. Among
newborns, carriage of S. aureus peaked at day 6 (238 out of 377, 63.1%) and GBS at day 3 (39 out of 377,
10.3%). Neonatal carriage of S. aureus at day 6 was associated with maternal carriage in the breast milk
adjusted OR 2.54; 95% CI 1.45e4.45, vaginal tract (aOR 2.55; 95% CI 1.32e4.92) and nasopharynx (aOR
2.49; 95% CI 1.56e3.97). Neonatal carriage of GBS at day 6 was associated with maternal carriage in the
breast milk (aOR 3.75; 95% CI 1.32e10.65) and vaginal tract (aOR 3.42; 95% CI 1.27e9.22).
Conclusions: Maternal colonization with S. aureus or GBS is a risk factor for bacterial colonization in
newborns. A. Roca, Clin Microbiol Infect 2017;23:974
© 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).Introduction
Among 6 million deaths in the under-ﬁves occurred in 2013,
more than half died of infections and approximately 44% occurred
during the neonatal period [1]. In sub-Saharan Africa, Staphylo-
coccus aureus [1] and Group B streptococcus (GBS) are common
causes of severe bacterial disease in neonates. However, few studies
have investigated how neonates become colonizedda necessary
step to diseasedwith these bacteria.
In sub-Saharan Africa S. aureus colonization peaks during the
ﬁrst week of life (c.80% prevalence), and then decreases steadilyambia, PO Box 273, Banjul,
Ltd on behalf of European Society
es/by/4.0/).until reaching a low plateau (c.20% prevalence) 10e20 weeks later
[2,3]. The timing of the peak during the neonatal period probably
reﬂects the role of vertical transmission. Indeed, studies in devel-
oped countries have shown that vaginal colonization in the mother
and breastfeeding are risk factors for S. aureus colonization during
the neonatal period [4e6]. One study conducted in sub-Saharan
Africa showed that mammillary colonization was a risk factor for
S. aureus carriage during early infancy [7].
Rectovaginal GBS colonization is common during pregnancy,
varying by geographical region from 11.1% in southern Asia to 22.4%
in sub-Saharan Africa [8], and is a major risk factor for neonatal
carriage [9e11]. It is estimated that 30%e70% of neonates born to
GBS-colonized mothers are colonized by bacteria from the mother,
and 1%e3% of those colonized develop severe disease.
Previous studies have shown that maternal and neonatal
S. aureus and GBS colonization in The Gambia is high [3,11,12]. Inof Clinical Microbiology and Infectious Diseases. This is an open access article under
Table 1
Baseline characteristics of study mothers and newborns
Characteristics n (%)
Mothers n ¼ 377
Age, years, median (interquartile range) 25.0 (22.0e29.0)
Ethnicitya Madinka 169 (45.4)
Fula 57 (15.3)
Jola 52 (14.0)
Other 94 (25.3)
Season of deliveryb Dry 251 (66.6)
Rainy 126 (33.4)
Mode of delivery Vaginal 377 (100.0)
Time from rupture of membranes 18 h 351 (93.1)
to delivery >18 h 26 (6.9)
Newborns n ¼ 377
Gender Male 200 (53.1)
Female 177 (46.9)
Apgar scorec 7e10 372 (98.9)
1e6 4 (1.1)
Birthweightd (median, IQR) 3.1 (2.9e3.4)
a Ethnicity missing for n ¼ 5 women.
b Rainy season: children born June to October.
c Apgar score missing in n ¼ 1.
d Birthweight missing in n ¼ 2.
(a) S. aureus carriage
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Fig. 1. Prevalence (%) of maternal and neonatal carriage of (a) Staphylococcus aureus
and (b) GBS during the follow-up period in the different biological sites (i.e. naso-
pharyngeal samples (NPS), breast milk samples (BM) and vaginal swabs (VS)). VS
collected at day 8e13 were included in the table as Day 14.
A. Roca et al. / Clinical Microbiology and Infection 23 (2017) 974e979 975this cohort study, we investigate the relationship between
maternal colonization at various body sitesdnasopharynx, vagina
and breast milkdand nasopharyngeal S. aureus and GBS coloniza-
tion in Gambian newborns.
Material and methods
Study design
This cohort study was a secondary analysis of data from the
placebo arm of a double-blind, placebo-controlled randomized trial
in which women in labour were randomized to receive a single
dose of 2 g of oral azithromycin or placebo (ratio 1: 1) [13]. Women
were recruited into the trial between April 2013 and April 2014
when attending the study health facility during labour; they had
provided written informed consent to participate in the study
during previous antenatal care visits. Women and newborns were
followed for up to 8weeks postpartum and biological samples were
collected during the ﬁrst 4 weeks [12,14].
Study site
The study was conducted at the Jammeh Foundation for Peace, a
government-run health centre located in Western Gambia that
manages 4500 deliveries/year. The population covers the main
ethnic groups in The Gambia and illiteracy is high. The climate of
the area is typical of the sub-Sahel region [15].
Study samples
During labour a nasopharyngeal swab and a vaginal swab were
collected from each woman, and within 4 h of birth a nasopha-
ryngeal swab was collected from the newborn (day 0). Additional
breast milk samples and maternal and newborn nasopharyngeal
swabs were collected at days 3, 6, 14 and 28 during household visits
conducted by study nurses and ﬁeld workers. A second vaginal
swab was collected by a study nurse or clinician when the mother
visited the health facility between day 8 and day 13. Sample
collectionwas stopped if the participant received antibiotics as part
of standard care.
Sample collection
Nasopharyngeal swabs were collected by inserting a calcium
alginate (Expotech USA Inc., Houston, TX, USA) swab into the pos-
terior wall of the nasopharynx and putting them into skimmed-
milketryptoneeglucoseeglycerol as previously described [16]. Low
vaginal swabs were collected by inserting a sterile cotton swab
(Sterilin Ltd, Newport, UK) 2e3 cm into the vagina and rotating
with a circular motion for 5 seconds, then placing the swabs into
the vials containing skimmed-milketryptoneeglucoseeglycerol
and placing in a cold box. To collect breast milk samples, the nipple
and areola of the breast fromwhich milk was takenwas disinfected
using sterile cotton soakedwith 0.02% chlorhexidine. Mothers were
then asked to manually express breast milk. The ﬁrst 0.5 mL was
discarded, and the following 1e2 mL was collected in another
sterile plastic bijoux (Thermo Fisher Scientiﬁc, Loughborough, UK)
bottle and put in a cold box. Samples were sent to the laboratory
and arrived within 8 h, where they were vortexed and stored at
e70C.
Laboratory procedures
Samples were thawed and processed in batches following
standard procedures [13]. During processing, 50 mL of each vial wasdispensed onto mannitol salt agar (CM0085; Oxoid, Basingstoke,
UK) and crystal violet blood agar (CM0331; Oxoid, Basingstoke,
UK þ0.002% crystal violet) for selective isolation of S. aureus and
GBS, respectively. After processing, samples were vortexed and
then stored at e70C.
Data management, statistical analysis and study deﬁnitions
Case-report forms and laboratory forms were reviewed before
being double entered into an OpenClinica (www.openclinica.com)
(a) S. aureus neonatal carriage
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Fig. 2. Frequency (%) of positive neonatal swabs for (a) Staphylococcus aureus and (b)
Group B streptococcus at each time-point.
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regularly. All analyses were conducted using STATA 14.1. For each
bacterium (S. aureus and GBS), we compared the prevalence of
nasopharyngeal colonization at day 6 in neonates whose mothers
were colonized at day 6 or earlier with the prevalence in neonatesTable 2
Prevalence of Staphylococcus aureus and Group B streptococcus in newborns at day 6 by
Site Bacterial carriage Neon
S. aureus
Vaginal swab S. aureus No 60.3
Yes 76.9
GBS No 62.2
Yes 67.7
NPS S. aureus No 54.8
Yes 75.8
GBS No 62.9
Yes 100.0
Breast milk S. aureus No 58.4
Yes 78.0
GBS No 65.3
Yes 47.8
GBS
Vaginal swab S. aureus No 4.5 (
Yes 9.2 (
GBS No 4.1 (
Yes 11.3
NPS S. aureus No 5.7 (
Yes 4.7 (
GBS No 5.3 (
Yes 0 (0/
Breast milk S. aureus No 5.9 (
Yes 3.3 (
GBS No 4.2 (
Yes 13.0
Abbreviations: aOR, adjusted OR; GBS, Group B streptococcus; NPS, nasopharyngeal swa
a OR adjusted by mother's age, ethnicity, mode of delivery and season.whose mothers were not colonized up to this time. Logistic
regression was used to adjust for confounding due to maternal age
and season. The population-attributable fractiondi.e. the propor-
tion of colonization events attributable to maternal colo-
nizationdwas calculated from the regression model using the
‘punaf’ command in STATA. We conducted separate analyses for the
different maternal sources of bacteria (vaginal tract, nasopharynx
and breast milk).
Ethical clearance
The trial was approved by the joint Gambia Government/MRC
Ethics Committees. An independent Data Safety and Monitoring
Board monitored the data quality and treatment safety.
Results
Study participants
There were 424 children in the placebo arm of the trial. We
excluded 18 twins, 27 children who were missing carriage data at
day 6 and two children whose mothers were missing carriage data
up to day 6. Hence the analysis was restricted to 377 newborns and
their mothers. The characteristics of newborns and mothers
included in this analysis are shown in Table 1. Overall, 98.7% (5954
out of 6032) of required samples were collected and included in the
analysis.
Maternal carriage of S. aureus and GBS
Maternal S. aureus carriage during the 28 days following de-
livery is shown in Fig. 1(a). Most women (73.1%; 264 out of the 361
women with all the samples collected) were carriers of S. aureus at
one or more time-points during the 28 days following delivery.
Carriage at at least at one time-point was higher in nasopharyngeal
swabs (51.5%; 186 out of 361womenwith all nasopharyngeal swabsmaternal bacterial carriage status
atal carriage % (n) aORa (95% CI) p-value
(188/312)
(50/65) 2.55 (1.32e4.92) 0.005
(196/315)
(42/62) 1.28 (0.71e2.33) 0.414
(125/228)
(113/149) 2.49 (1.56e3.97) <0.001
(236/375)
(2/2) d d
(167/286)
(71/91) 2.54 (1.45e4.45) 0.001
(216/331)
(22/46) 0.45 (0.23e0.85) 0.015
14/312)
6/65) 2.69 (0.93e7.34) 0.069
13/315)
(7/62) 3.42 (1.27e9.22) 0.015
13/228)
7/149) 0.80 (0.31e2.09) 0.655
20/375)
2) NA d
17/286)
3/91) 0.53 (0.15e1.86) 0.319
14/331)
(6/46) 3.75 (1.32e10.65) 0.013
b.
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breast milk samples collected) and vaginal tract (24.5%; 92 out of
375 women with all vaginal tract samples collected).
Maternal GBS carriage during the 28 days following delivery is
shown in Fig. 1(b). Overall, 31.6% of women (114 out of 361) were
carriers at one or more time-points. Carriage at at least at one
time-point was more common in the vaginal tract (23.5%; 88 out
of 375) and breast milk (15.8%; 57 out of 361) than in NPS (1.1%; 4
out of 361). In the breast milk samples, carriage decreased from
7.7% (29 out of 377) at day 6 to 1.7% (6 out of 363) at day 28
(p < 0.001).
Neonatal carriage of S. aureus and GBS
Most children (81.6%; 292 of the 358 children with all samples
collected) were carriers of S. aureus at some time-point during the
neonatal period. The prevalence of carriage increased rapidly from
4.0% at birth (15 out of 377) to a peak of 63.1% (238 out of 377) at
day 6 (Fig. 1a) and decreased to 35.6% at day 28 (128 out of 360).
The greatest number of new episodes of carriage occurred on day 3
(Fig. 2a).
Neonatal carriage of GBS was lower than that of S. aureus, but
still relatively common (12.0%; 43 out of 358). New infections
occurred throughout the neonatal period (Fig. 2b), although theTable 3
Epidemiological and demographic characteristics as potential risk factors for Staphylococ
Variable Categories
Delivery characteristics
Season Dry (NovembereMay)
Rainy
Day of the week Weekend
Week day
Time of the day Not working hours
Working hours (8 ame4 pm
Low birthweight No
Yes
Gender Female
Male
Apgar score (at birth) 1e6
7e10
Hours from membrane rupture to birth <1 hour
>1 hour
Maternal characteristics
Maternal age 18e19 years
20e29 years
30 years
Ethnic group Mandinka
Wollof
Jola
Fula
Other
Formal education <1 year
1 year
Household characteristics
Mother baths the newborn No
Yes
Mother cooks with child on the back No
Yes
Children <5 years sleeping with newborn No
Yes
People in the household 2e4
>4
Three quantiles of Socio Economical Status score 1, poorest
2
3, least poor
People smoke No
Yes
Use of camphor No
Yesnumber varied with time. The largest number occurred at day 3,
coinciding with the peak prevalence (10.3%; 39 out of 377). One in
20 children (18 out of 366) were still carriers at day 14 (Fig. 1b).
Association between maternal and neonatal colonization
Neonatal carriage of S. aureus at day 6 was associated with the
presence of bacteria in the breast milk (adjusted OR 2.54; 95% CI
1.45e4.45), the mother's vaginal tract (aOR 2.55; 95% CI 1.32e4.92)
and the mother's nasopharynx (aOR 2.49; 95% CI 1.56e3.97)
(Table 2). Carriage of GBS was associated with the presence of
bacteria in breast milk (aOR 3.75; 95% CI 1.32e10.65) and vaginal
tract (aOR 3.42; 95% CI 1.27e9.22) (Table 2).
Overall, 21% (95% CI 13e29) of neonatal S. aureus carriage and
31% (95% CI 2e51) GBS carriage was attributable to maternal
colonization.
Other risk factors for neonatal colonization
The prevalence of S. aureus carriage at day 6 varied between the
different ethnic groups (Table 3). The prevalence of GBS carriage at
day 6 was lower among neonates whosemothers were >30 years of
age and those who had more than two children living with them in
the household (Table 4).cus aureus nasopharyngeal carriage in newborns at day 6
n Carriage with S. aureus at day 6
% (n) OR (95% CI) p-value
251 60.6 (152)
126 68.3 (86) 1.40 (0.89e2.20) 0.174
52 59.6 (31)
325 63.7 (207) 1.19 (0.65e2.16) 0.643
121 63.3 (162)
) 256 62.8 (76) 1.02 (1.32e2.18) 0.931
348 63.5 (221)
29 58.6 (17) 0.81 (0.38e1.76) 0.689
177 62.1 (110)
200 64.0 (128) 1.09 (0.72e1.65) 0.749
4 50.0 (2)
372 63.2 (235) 1.72 (0.24e12.32) 0.628
136 61.8 (84)
53 60.4 (32) 0.94 (0.49e1.81) 0.869
36 69.4 (25) Baseline 0.631
247 61.5 (152) 0.70 (0.33e1.50)
94 64.9 (61) 0.80 (0.36e1.86)
169 66.3 (113) Baseline 0.029
43 72.1 (31) 1.31 (0.63e2.75)
52 65.4 (34) 0.96 (0.50e1.85)
57 61.4 (35) 0.81 (0.43e1.51)
51 43.1 (22) 0.39 (0.20e0.73)
187 63.1 (118)
181 62.4 (113) 0.97 (0.64e1.48) 0.914
161 67.1 (108)
203 60.1 (122) 0.74 (0.48e1.14) 0.171
334 62.3 (208)
31 61.3 (19) 0.96 (0.45e1.84) 0.914
203 60.6 (123)
168 64.9 (109) 1.20 (0.79e1.84) 0.396
192 62.5 (120)
181 63.0 (114) 1.02 (0.67e1.55) 0.923
109 57.8 (63) Baseline 0.308
117 67.5 (79) 1.52 (0.88e2.61)
101 64.4 (65) 1.32 (0.76e2.30)
343 63.8 (219)
31 51.6 (16) 0.60 (0.29e1.26) 0.181
269 63.6 (171)
105 61.0 (64) 0.89 (0.56e1.42) 0.638
Table 4
Epidemiological and demographic characteristics as potential risk factors for group B streptococcus nasopharyngeal carriage in newborns at day 6
Variable Categories N Carriage with group B streptococcus at day 6
% (n) OR (95% CI) p-value
Delivery characteristics
Season Dry (NovembereMay) 251 5.6 (14)
Rainy 126 4.8 (6) 0.85 (0.32e2.26) 0.813
Day of the week Weekend 52 3.8 (2)
Week day 325 5.5 (18) 1.47 (0.33e6.51) 1.000
Time of the day Not working hours 121 5.1 (13)
Working hours (8 ame4 pm) 256 5.8 (7) 1.15 (0.45e2.95) 0.807
Low birthweight No 348 5.7 (20)
Yes 29 0 NA NA
Gender Female 177 3.9 (7)
Male 200 6.5 (13) 1.71 (0.67e4.38) 0.265
Apgar score (at birth) 1e6 4 0
7e10 372 5.4 (20) NA NA
Hours from membrane rupture to birth <1 hour 136 4.4 (6)
1 hour 53 9.4 (5) 2.26 (0.66e7.74) 0.297
Maternal characteristics
Maternal age 18e19 years 36 2.8 (1) Baseline 0.044
20e29 years 247 7.3 (18) 2.75 (0.36e21.26)
30 years 94 1.1 (1) 0.38 (0.02e6.18)
Ethnic group Mandinka 169 6.5 (11) Baseline 0.760
Wollof 43 2.3 (1) 0.34 (0.04e2.72)
Jola 52 7.7 (4) 1.20 (0.36e3.93)
Fula 57 3.5 (2) 0.53 (0.11e2.43)
Other 51 3.9 (2) 0.59 (0.13e2.74)
Formal education <1 year 187 5.3 (10)
1 year 181 5.5 (10) 1.04 (0.42e2.55) 1
Household characteristics
Mother baths the newborn No 161 6.8 (11)
Yes 203 4.4 (9) 0.63 (0.26e1.57) 0.322
Mother cooks with child on the back No 334 5.4 (18)
Yes 31 3.2 (1) 0.59 (0.08e4.45) 0.608
Children <5y sleeping with newborn No 203 5.9 (12)
Yes 168 4.8 (8) 0.80 (0.32e1.99) 0.626
People in the household 2e4 192 5.7 (11)
>4 181 5.0 (9) 0.86 (0.35e2.13) 0.746
3 quantiles of Socio Economical Status score 1, poorest 109 4.6 (5) Baseline 0.558
2 117 5.1 (6) 1.12 (0.33e3.80)
3, least poor 101 7.9 (8) 1.79 (0.57e5.66)
People smoke No 343 5.0 (17)
Yes 31 9.7 (3) 2.05 (0.57e7.44) 0.273
Use of camphor No 269 6.7 (18)
Yes 105 1.9 (2) 0.27 (0.06e1.19) 0.083
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This study has shown that carriage of S. aureus and GBS is
common among Gambian women and their newborns, and that
maternal colonization is an important risk factor for neonatal
colonization. Neonates were more likely to be colonized with
S. aureus and GBS if the bacteria were present in the mother's
vaginal tract, breast milk or nasopharynx (only S. aureus for the last
of these). Combined, these sites explained 21% of S. aureus neonatal
colonization and 31% of GBS neonatal colonization at day 6.
In keeping with our results, in Gabon, S. aureus maternal car-
riagewas associated with neonatal carriage [7], though only 5.6% of
neonatal colonization was attributable to maternal transmission.
The difference between this estimate and our estimate could be
explained by the fact that investigators in Gabon did not collect
vaginal swabs and the fact that they collected samples from babies
after the neonatal period, when other sources of infectionmay have
played a greater role. The fraction of neonatal carriage explained by
maternal carriage in our study is probably also underestimated
because important sources of maternal transmission were not
sampled (i.e. oropharyngeal and nasal swabs for S. aureus and rectal
swabs for GBS); and additional sources of neonatal carriage were
not evaluated (i.e. skin, umbilicus, rectum and ears).Maternal vaginal GBS carriage and breast milk carriage were
common and persisted throughout the neonatal period. GBS car-
riage in breast milk has the potential to increase the risk of late-
onset neonatal sepsis [17], and this may explain why the inci-
dence of GBS disease remains high in sub-Saharan Africa after the
early neonatal period [18]. Our results suggest that vaginal
screening for GBS carriage would not sufﬁce to identify children at
high risk of invasive GBS disease [9,10,19] as 18% of womenwho had
a negative swab at birth were carriers of GBS at some point during
the neonatal period. However, some of these women may have
been colonized at birth because we used sub-optimal methods for
investigating for GBS colonization (i.e. vaginal rather than
rectovaginal).
Our analysis has several limitations. First, as previously
mentioned, we did not collect oropharyngeal, nasal or rectal
swabs from the mother or skin, umbilical, rectal and ear swabs
from the babies. The fact that we did not collect these swabs is of
particular importance because it is likely that we underestimated
the prevalence of maternal and neonatal colonization of both
S. aureus and GBS; and diluted the fraction of neonatal carriage
explained by maternal carriage. Second, carriage prevalence may
have been underestimated because only healthy mothers and
their babies were recruited into the study, and women and
A. Roca et al. / Clinical Microbiology and Infection 23 (2017) 974e979 979babies who participated in the trial received better health care.
Third, swabs were not collected from siblings and other close
contacts, so it was not possible to compare maternal trans-
mission with that from other sources. Fourth, we cannot exclude
the possibility that the observed association between neonatal
colonization at day 6 and maternal colonization is explained, at
least in part, by transmission from the neonate to the mother as
was observed in the Gabon study [7]. Lastly, the study was
designed to assess the impact of maternal carriage on neonatal
carriage, it was not designed to assess its impact on neonatal
disease.
Due to the high burden of maternal colonization and the role of
the mothers in neonatal colonization, Gambian newborns are
rapidly colonized by S. aureus and GBS over the ﬁrst month of life
and therefore are at high risk for neonatal sepsis. Interventions that
target pregnant women in sub-Saharan Africa are likely to reduce
neonatal carriage and associated disease. On account of the high
burden of maternal carriage in the region, it may be reasonable to
assume that most children in sub-Saharan Africa are at high risk of
neonatal sepsis. Interventions that target maternal colonization
(e.g. maternal antibiotics or maternal vaccination) are expected to
reduce neonatal colonization and associated sepsis. However, other
sources of neonatal colonization should also be considered. For
prevention strategies that involve the use of wide-spectrum pro-
phylactic antibiotics, continuous monitoring of the potentially
negative effect of the intervention on antibiotic resistance will need
to be in place.
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